• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Chiron Real Estate Inc.

    4/8/26 4:46:12 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate
    Get the next $XRN alert in real time by email
    DEFA14A 1 tm261555d3_defa14a.htm DEFA14A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No.          )
     

     

     

    Filed by the Registrant x

    Filed by a Party other than the Registrant ¨

     

    Check the appropriate box:

    ¨Preliminary Proxy Statement
    ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ¨Definitive Proxy Statement
    xDefinitive Additional Materials
    ¨Soliciting Material under §240.14a-12

     

    Chiron Real Estate Inc.

    (Name of Registrant as Specified In Its Charter) 

     

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

    xNo fee required.
    ¨Fee paid previously with preliminary materials.
    ¨Fee paid on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     

     

     

    GRAPHIC

    NAME & ADDRESS HERE STOCKHOLDERS ARE CORDIALLY INVITED TO ATTEND THE ANNUAL MEETING. To the Stockholders of Chiron Real Estate Inc: Notice is hereby given that the Annual Meeting of Stockholders of Chiron Real Estate Inc. will be held May 20, 2026 at 10:00 a.m. Eastern Daylight Time. The Annual Meeting will be held virtually, by means of remote communications. In order to attend the meeting, you must register at https://web.viewproxy.com/XRN/2026 by 11:59 p.m. ET on May 18, 2026. The Board of Directors recommends that you vote “FOR” each of the nominees for directors in Proposal 1, and “FOR” Proposals 2, 3, and 4. 1. To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies. 01. Jeffrey M. Busch 02. Matthew Cypher 03. Mark Decker, Jr. 04. Zhang Huiqi 05. Paula R. Crowley 06. Lori Wittman 2. Advisory vote to approve the compensation of the Company’s named executive officers as described in the Proxy Statement. 3. To approve an amendment to our 2016 Equity Incentive Plan to extend the term through May 20, 2036 and to increase the number of shares reserved for issuance thereunder by 300,000. 4. To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. NOTE: To consider and vote upon such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. Important Notice Regarding the Internet Availability of Proxy Materials for the Annual Meeting of Stockholders to be held virtually on May 20, 2026 at 10:00 a.m. Eastern Daylight Time. This communication is not a form of voting and presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The Proxy Statement and our 2025 Annual Report on Form 10-K are available at https://web.viewproxy.com/XRN/2026 If you want to receive a paper or email copy of these documents, you must request one by following the instructions on the reverse side of this Notice on or before May 12, 2026 to facilitate timely delivery. There is no charge to you for requesting a copy. Important information regarding the Internet availability of the Company’s proxy materials, instructions for accessing your proxy materials and voting online, and instructions for requesting paper or e-mail copies of your proxy materials are outlined in this Notice. You must use the 11-digit Control Number located in the box to attend the Annual Meeting virtually, to vote via Internet, or to request proxy materials. CONTROL NUMBER

    GRAPHIC

    The Securities and Exchange Commission rules permit us to make our proxy materials available to our stockholders via the Internet. CONTROL NUMBER Materials for this Annual Meeting and future meetings may be requested by one of the following methods: Internet Go to https://web.viewproxy.com/XRN/2026. Have the 11-digit Control Number available when you access the website and follow the instructions. E-Mail By e-mail at: [email protected] * If requesting material by e-mail, please send a blank e-mail with the company name and your 11-digit Control Number in the subject line. No other requests, instructions, or other inquiries should be included within this email request. Telephone Call 1-877-777-2857 Toll Free VOTING METHODS Via Internet prior to the Annual Meeting: Go to https://www.AALvote.com/XRN. Have your 11-digit Control Number available and follow the prompts. • Your electronic vote prior to the Annual Meeting authorizes the named proxies to vote your shares in the same manner as if you marked, signed, dated, and returned a proxy card. Via Internet during the Annual Meeting: Go to https://www.AALvote.com/XRN Have your 11-digit Control Number available and follow the prompts.

    Get the next $XRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XRN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by General Counsel and Secretary Barber Jamie Allen

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    2/25/26 9:57:31 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by CFO and Treasurer Kiernan Robert J

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    2/25/26 9:57:04 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by COO Holley Danica

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    2/25/26 9:56:39 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

    Busch brings public company leadership and capital markets experience to support Ignite's next phase of growth Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most

    3/19/26 8:15:00 AM ET
    $ADTX
    $GMRE
    $XRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    –Completes Corporate Rebrand– –Announces 2026 Strategic Objectives & Full Year 2026 Core FFO Guidance– –Announces Change from Quarterly to Monthly Dividends– Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced financial results for the three and twelve months ended December 31, 2025 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "We're about eight months into the transformation of the business and we are making great progress. I'm grateful for all the hard work that's produced these early results and the support of our Board. We can see the business we want and a path to get there. As this quarter demonstrates, we have a s

    2/25/26 4:05:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    SEC Filings

    View All

    SEC Form DEFA14A filed by Chiron Real Estate Inc.

    DEFA14A - Chiron Real Estate Inc. (0001533615) (Filer)

    4/8/26 4:46:12 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    SEC Form DEF 14A filed by Chiron Real Estate Inc.

    DEF 14A - Chiron Real Estate Inc. (0001533615) (Filer)

    4/8/26 4:43:50 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Chiron Real Estate Inc.

    SCHEDULE 13G/A - Chiron Real Estate Inc. (0001533615) (Subject)

    3/26/26 5:16:48 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Leadership Updates

    Live Leadership Updates

    View All

    Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

    Busch brings public company leadership and capital markets experience to support Ignite's next phase of growth Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most

    3/19/26 8:15:00 AM ET
    $ADTX
    $GMRE
    $XRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate